...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

But what is said, in the first NR by RVX on March 23, Clearly Stated on its second paragraph that....

"Furthermore, Apabe.. is Known to Inhibit Expression of ACE2, the receptor utilized by the novel coronavirus particles to gain is entery into human cells".

It therefore appears than one part of the story, entery into the cell" has been already known!!!

Share
New Message
Please login to post a reply